Aziyo biologics and sientra announce simpliderm® partnership to improve women's access to biologics for soft tissue reconstruction

Silver spring, md. and irvine, calif., march 22, 2023 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo) (“aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, and sientra, inc. (nasdaq: sien) (“sientra”), a medical aesthetics company uniquely focused on plastic surgery, today announced they have entered into an agreement to expand the distribution of aziyo's simpliderm product line. under the agreement terms, aziyo will grant sientra certain non-exclusive rights in the united states to market, sell and distribute simpliderm for select use in reconstruction surgery.
AZYO Ratings Summary
AZYO Quant Ranking